CD8A and myeloid sarcoma: Autoimmune attacks may engage, as dominant effectors, CD8+ T cells (e.g. T1D, vitiligo, AA (6, 92, 93)), CD4+ T cells (e.g. MS, SLE, RA, IBD, EAE, autoimmune thyroid diseases, psoriasis (94)), NK cells (e.g. AA, SLE, RA, MS, psoriasis, T1D (95, 96)) or autoantibodies (e.g. SLE, T1D, psoriasis, Grave’s disease, IBD, MS (97)).